PixCell Medical Technologies Ltd (PixCell), a subsidiary of Soulbrain Holdings Co Ltd, is a medical device company that develops, produces, and markets portable medical diagnostic products for point-of-care testing. The company’s product comprises hemoscreen, a portable hematology analyzer used for blood sampling and analysis. PixCell’s products are based on viscoelastic focusing technology and single-use cartridges. The company offers cartridge for platelets aggregation testing. It also develops diagnostic products related to hemostatic and immuno-based disorders. The company’s technology is a platform for the development of portable diagnostic devices based on whole blood analysis. It has its operations across Switzerland, Austria, the Netherlands, Australia, New Zealand, Israel, the US, and the Czech Republic. PixCell is headquartered in Yokneam Ilit, Haifa, Israel.
This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.
The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.
This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.
The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.
Scope:
- The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments
- The report analyzes all pipeline products in development for the company PixCell Medical Technologies Ltd
- The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)
- The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date
- The report provides detailed description of products in development, technical specification and functions
- The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design, trial status and phase, estimated start and end date.
Reasons to Buy:
- Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape
- Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio
- To formulate effective Research & Development strategies
- Develop market-entry and market expansion strategies
- Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return
- Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Develop competition strategies by identifying the status and likely launch of the competitors’ pipeline products through review of the clinical trials, stage and of development, etc
- Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio
Table of Contents
- PixCell Medical Technologies Ltd Company Overview
- PixCell Medical Technologies Ltd Company Snapshot
- PixCell Medical Technologies Ltd Pipeline Products and Ongoing Clinical Trials Overview
- PixCell Medical Technologies Ltd - Pipeline Analysis Overview
- PixCell Medical Technologies Ltd - Key Facts
- PixCell Medical Technologies Ltd - Major Products and Services
- PixCell Medical Technologies Ltd Pipeline Products by Development Stage
- PixCell Medical Technologies Ltd Pipeline Products Overview
- Diagnostic Test - CD4+ Lymphocytes
- Diagnostic Test - CD4+ Lymphocytes Product Overview
- Diagnostic Test - Malaria
- Diagnostic Test - Malaria Product Overview
- Diagnostic Test - Tuberculosis
- Diagnostic Test - Tuberculosis Product Overview
- HemoScreen - Cancer
- HemoScreen - Cancer Product Overview
- Hemoscreen - Heart Failure
- Hemoscreen - Heart Failure Product Overview
- HemoScreen - Home Use
- HemoScreen - Home Use Product Overview
- Hemoscreen - Sepsis Assay
- Hemoscreen - Sepsis Assay Product Overview
- HemoScreen Platelets Aggregation Test Cartridge
- HemoScreen Platelets Aggregation Test Cartridge Product Overview
- PixCell Medical Technologies Ltd - Key Competitors
- PixCell Medical Technologies Ltd - Key Employees
- PixCell Medical Technologies Ltd - Locations And Subsidiaries
- Head Office
- Recent Developments
- PixCell Medical Technologies Ltd, Recent Developments
- Nov 29, 2023: Research Team at UNC Validates PixCell Medical's HemoScreen as Game-Changer for Clozapine Monitoring in Psychiatry
- Aug 23, 2023: FDA Clears Pixcell Medical's Hemoscreen Point Of Care CBC For Direct Capillary Sampling Significantly Enhancing Ease-of-use & Testing Throughput
- Jun 20, 2023: PixCell Medical Appoints Guy Frak as New Chief Commercial Officer
- Nov 16, 2022: New Age for Point-of-Care Diagnostics: PixCell Medical's HemoScreen surpasses leading lab hematology analyzer sysmex XN in flagging of abnormal WBC
- Nov 09, 2022: New study highlights HemoScreen's capability to detect leukocyte abnormalities
- Sep 06, 2022: Pixcell Medical partners with Insight Medical to distribute the hematology point-of-care analyzer Hemoscreen in Papua New Guinea
- Jun 08, 2022: PixCell Medical Names Mark Erez as Chief Financial Officer
- Apr 25, 2022: PixCell Medical Appoints Ryan Venturi as General Manager of Newly Opened US Office
- Apr 12, 2022: PixCell's HemoScreen takes home gold and Best-in-Show awards in 2022 Medical Design Excellence Competition
- Mar 08, 2022: Katalyst Diagnostics becomes sole distributor of PixCell Medical's HemoScreen in the UK and Ireland
- Appendix
- Methodology
- About the Publisher
- Contact the Publisher
- Disclaimer
- PixCell Medical Technologies Ltd Pipeline Products and Ongoing Clinical Trials Overview
- PixCell Medical Technologies Ltd Pipeline Products by Equipment Type
- PixCell Medical Technologies Ltd Pipeline Products by Indication
- PixCell Medical Technologies Ltd, Key Facts
- PixCell Medical Technologies Ltd, Major Products and Services
- PixCell Medical Technologies Ltd Number of Pipeline Products by Development Stage
- PixCell Medical Technologies Ltd Pipeline Products Summary by Development Stage
- Diagnostic Test - CD4+ Lymphocytes - Product Status
- Diagnostic Test - CD4+ Lymphocytes - Product Description
- Diagnostic Test - Malaria - Product Status
- Diagnostic Test - Malaria - Product Description
- Diagnostic Test - Tuberculosis - Product Status
- Diagnostic Test - Tuberculosis - Product Description
- HemoScreen - Cancer - Product Status
- HemoScreen - Cancer - Product Description
- Hemoscreen - Heart Failure - Product Status
- Hemoscreen - Heart Failure - Product Description
- HemoScreen - Home Use - Product Status
- HemoScreen - Home Use - Product Description
- Hemoscreen - Sepsis Assay - Product Status
- Hemoscreen - Sepsis Assay - Product Description
- HemoScreen Platelets Aggregation Test Cartridge - Product Status
- HemoScreen Platelets Aggregation Test Cartridge - Product Description
- PixCell Medical Technologies Ltd, Key Employees
- Glossary
- PixCell Medical Technologies Ltd Pipeline Products by Equipment Type
- PixCell Medical Technologies Ltd Pipeline Products by Development Stage
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- Tzamal Medical Group Ltd
- Meditrac Ltd
- Keren Medical Ltd.
